Skip to main content
OpenTrials
Completed

NCT Number: NCT03830359

Efficacy, Safety of T2769 in Dry Eye Disease

Efficacy of T2769 in Dry Eye Desease

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Syndrome Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital Universitaire Tahar Sfar, Mahdia, Tunisia

Loading trial locations.

About this study

Multicenter and open study

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed and dated informed consent
  • Male or female aged from ≥ 18 years old
  • Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to study screening

Exclusion criteria

  • Best far corrected visual acuity ≤ 2/10
  • Severe blepharitis Severe dry eye

Treatment and study plan

T2769

Other

At least 55 enrolled patients for at least 50 evaluable patients treated by T2769 for 42 days

Other names: Ophthalmic solution

Primary outcomes

  1. Ocular Symptomatology

    Time frame: Baseline and Day 42

    Change from baseline in ocular symptomatology on a Visual Analog Scale (0=No discomfort and 100=Maximal discomfort) at Day 42.

Sponsors and collaborators

Lead sponsor

Laboratoires Thea

Industry

Registry information

Official study title

Efficacy and Safety Assessment of T2769 in Patients With Moderate to Severe Dry Eye Syndrome

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Feb 5, 2019
Registry last updated
Mar 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.